• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corp (NY: GKOS )

    126.90 -1.34 (-1.04%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 583,249
    Open 128.30
    Bid (Size) 124.98 (1)
    Ask (Size) 133.58 (1)
    Prev. Close 128.24
    Today's Range 126.69 - 130.31
    52wk Range 59.22 - 136.60
    Shares Outstanding 54,950,459
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
    From Glaukos Corporation
    Via Business Wire
    Navigating 11 Analyst Ratings For Glaukos
    Via Benzinga

    Performance

    YTD
    +64.63%
    +64.63%
    1 Month
    +1.12%
    +1.12%
    3 Month
    +4.80%
    +4.80%
    6 Month
    +29.19%
    +29.19%
    1 Year
    +92.27%
    +92.27%

    More News

    Read More
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
    Via Benzinga
    Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    10 Analysts Have This To Say About Glaukos
    Via Benzinga
    Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
    Via Benzinga
    Analyst Ratings For Glaukos
    Via Benzinga
    GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Glaukos Announces Second Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    7 Leading MedTech Stocks for Next-Gen Health Solutions
    Via InvestorPlace
    This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
    Via Benzinga
    Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
    From Glaukos Corporation
    Via Business Wire
    5 Analysts Have This To Say About Glaukos
    Via Benzinga
    Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
    Via Benzinga
    Topics Earnings
    Exposures Financial
    C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Glaukos Announces First Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces the Release of its 2023 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
    From Glaukos Corporation
    Via Business Wire
    Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
    From Glaukos Corporation
    Via Business Wire
    Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.